Bethesda, MD, United States of America

Jane B Trepel

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 1995-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Jane B Trepel: Innovator in Pharmacodynamics

Introduction

Jane B Trepel is a distinguished inventor based in Bethesda, MD (US). She has made significant contributions to the field of pharmacodynamics, holding a total of 5 patents. Her work focuses on developing methods for screening drug effects and treating various cancers.

Latest Patents

Among her latest patents, one notable invention is related to pharmacodynamic assays. This invention provides methods for quickly and easily screening mixed cell samples for a pharmacodynamic effect to a drug or test agent. Another significant patent involves the use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase for treating various cancers, including prostatic adenocarcinoma. This patent outlines methods of treatment using inhibitors such as lovastatin, detailing dosing ranges, schedules, and potential toxicities.

Career Highlights

Throughout her career, Jane has worked with prominent organizations, including the United States of America as represented by the Department of Health and the United States of America as represented by the Secretary of Health. Her innovative approaches have paved the way for advancements in cancer treatment and drug screening methodologies.

Collaborations

Jane has collaborated with notable colleagues, including Charles E Myers and Wei-Gang Fang. Their combined expertise has contributed to the success of her research and inventions.

Conclusion

Jane B Trepel's contributions to pharmacodynamics and cancer treatment exemplify her dedication to innovation in the medical field. Her patents reflect a commitment to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…